Enhance Patient Care with Nuclear Medicine and Molecular Imaging - EM is organized by Johns Hopkins Medicine (JHM).
Release date: July 26, 2017
Expiration date: July 26, 2020
This program will be especially applicable to nuclear medicine physicians and radiologists who interpret nuclear medicine studies as well as those who treat patients with radioactive isotopes. It will also be useful for referring physicians who want to learn more about state-of-the-art and emerging nuclear medicine studies. The program will also be appropriate for technologists and others interested in using current state-of-the art nuclear medicine techniques.
Certification Designation Statement:
The Johns Hopkins University School of Medicine designates this enduring material activity for a maximum of 10.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
The Johns Hopkins University has approved this activity for 10.75 contact hours for non-physicians.
Nuclear Medicine has long been recognized as the imaging modality that can best assess function and the results of events that occur at a molecular level. The increased understanding of genomic and specific molecular mechanisms is now being more widely applied in clinical situations. The goal of this program is to discuss how nuclear molecular imaging can increase the effectiveness of many studies performed daily in both academic and community hospital imaging centers. Johns Hopkins faculty and outside experts present their experience with PET/CT and SPECT/CT and illustrate their results with studies from their patient populations.
After participating in the activity, the participant will demonstrate the ability to:
• Interpret nuclear medicine studies with greater confidence.
• Recognize new ways to obtain quantitative data.
• Discuss different nuclear medicine treatment options available to patients for variety of disease states,
including emerging techniques.
Nuclear Medicine, Radiology